Clinicopathologic predictors of recurrence and overall survival in adenoid cystic carcinoma of the head and neck: A single institutional experience at a tertiary care center

Head and Neck

Volumn 36, Issue 12, 2014, Pages 1705-1711

  Marcinow, Anna ^a   Ozer, Enver ^a   Teknos, Theodoros ^a   Wei, Lai ^a   Hurtuk, Agnes ^b   Old, Matthew ^a   Agrawal, Amit ^a   Carrau, Ricardo ^a   Iwenofu, Obiajulu H ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b Resurrection Medical Group   (United States)

Author keywords

Adenoid cystic carcinomas; Disease free survival; Head and neck; Overall survival; Prognostic factors

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR ALPHA; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN P53;

ADENOID CYSTIC CARCINOMA; ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FACE PAIN; FEMALE; FOLLOW UP; GENDER; HEAD AND NECK ADENOID CYSTIC CARCINOMA; HEAD AND NECK CARCINOMA; HEAD AND NECK TUMOR; HEADACHE; HEARING IMPAIRMENT; HISTOPATHOLOGY; HOARSENESS; HUMAN; IMMUNOHISTOCHEMISTRY; LONG TERM SURVIVAL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MINOR SALIVA GLAND; MULTIMODALITY CANCER THERAPY; NECK DISSECTION; NEUROLOGIC DISEASE; OTALGIA; OVERALL SURVIVAL; PARESTHESIA; PERINEURAL INVASION; RETROSPECTIVE STUDY; SALIVARY GLAND DISEASE; WEAKNESS; CANCER STAGING; CARCINOMA, ADENOID CYSTIC; EPIDEMIOLOGY; HEAD AND NECK NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; RISK FACTOR; SEX DIFFERENCE; SURVIVAL RATE; TERTIARY CARE CENTER; TREATMENT OUTCOME; TUMOR INVASION; TUMOR RECURRENCE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ADENOID CYSTIC; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SURVIVAL RATE; TERTIARY CARE CENTERS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84912016345     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23523     Document Type: Article

References (26)

1. Kim KH, Sung MW, Chung PS, Rhee CS, Park CI, Kim WH. Adenoid cystic carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1994;120: 721-726.
2. Fordice J, Kershaw C, El-Naggar A, Goepfert H. Adenoid cystic carcinoma of head and neck: Predictors of morbidity and mortality. Arch Otolaryngol Head Neck Surg 1999;125: 149-152.
3. Triantafillidou K, Dimitrakopoulos J, Iordanidis F, Koufogiannis D. Management of adenoid cystic carcinoma of minor salivary glands. J Oral Maxillofac Surg 2006;64: 1114-1120.
4. Miglianico L, Eschwege F, Marandas P, Wibault P. Cervico-facial adenoid cystic carcinoma: Study of 102 cases. Influence of radiation therapy. Int J Radiat Oncol Biol Phys 1987;13: 673-678.
5. Khan AJ, DiGiovanna MP, Ross DA, et al. Adenoid cystic carcinoma: A retrospective clinical review. Int J Cancer 2001;96: 149-158.
6. Prokopakis EP, Snyderman CH, Hanna EY, Carrau RL, Johnson JT, D'Amico F. Risk factors for local recurrence of adenoid cystic carcinoma: The role of postoperative radiation therapy. Am J Otolaryngol 1999;20: 281-286.
7. Norberg-Spaak L, Dardick I, Ledin T. Adenoid cystic carcinoma: Use of cell proliferation. BCL-2 expression, histologic grade, and clinical stage as predictors of clinical outcome. Head Neck 2000;22: 489-497.
8. Huang M, Ma D, Sun K, Yu G, Guo C, Gao F. Factors influencing survival rate in adenoid cystic carcinoma of the salivary glands. Int J Oral Maxillofac Surg 1997;26: 435-439.
9. Oplatek A, Ozer E, Agrawal A, Bapna S, Schuller DE. Patterns of recurrence and survival of head and neck adenoid cystic carcinoma after definitive resection. Laryngoscope 2010;120: 65-70.
10. Sobin LH, Gospodarowicz MK, Wittekind C, editors. TNM-classification of Malignant Tumours (UICC International Union Against Cancer), 7th ed. New Jersey, Chichester, Oxford: Wiley-Blackwell; 2009.
11. Brown JS. Prognostic factors in oral, oropharyngeal and salivary gland cancer. In: Booth PW, Schendel SA, Hausamen JE, editors. Maxillofacial Surgery (volume 1). Edinburgh, London, New York: Churchill Livingstone; 1999. pp 291-308.
12. Barrera JE, Shroyer KR, Said S, et al. Estrogen and progesterone receptor and p53 gene expression in adenoid cystic cancer. Head Neck Pathol 2008; 2: 13-18.
13. Luo SD, Su CY, Chuang HC, Huang CC, Chen CM, Chien CY. Estrogen receptor overexpression in malignant minor salivary gland tumors of the sinonasal tract. Otolaryngol Head Neck Surg 2009;141: 108-113.
14. Motta Rda R, Zettler CG, Cambruzzi E, Jotz GP, Berni RB. Ki-67 and p53 correlation prognostic value in squamous cell carcinomas of the oral cavity and tongue. Braz J Otorhinolaryngol 2009;75: 544-549.
15. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53: 457-481.
16. Hosmer D, Lemeshow S. Applied survival analysis: Regression modeling of time to event data. New York: John Wiley & Sons: 1991. p 159.
17. Garden AS, Weber RS, Morrison WH, Ang KK, Peters LJ. The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation. Int J Radiat Oncol Biol Phys 1995;32: 619-626.
18. Nascimento AG, Amaral AL, Prado LA, Kligerman J, Silveira TR. Adenoid cystic carcinoma of salivary glands. A study of 61 cases with clinicopathologic correlation. Cancer 1986;57: 312-319.
19. Pitman KT, Prokopakis EP, Aydogan B, et al. The role of skull base surgery for the treatment of adenoid cystic carcinoma of the sinonasal tract. Head Neck 1999;21: 402-407.
20. Whear NM, Addy JM. Adenoid cystic carcinoma of the sublingual gland- an unusual presentation. Br J Oral Maxillofac Surg 1993;31: 113-116.
21. Ellington CL, Goodman M, Kono SA, et al. Adenoid cystic carcinoma of the head and neck: Incidence and survival trends based on 1973-2007 Surveillance, Epidemiology, and End Results data. Cancer 2012;118: 4444-4451.
22. Elkin AD, Jacobs CD. Tamoxifen for salivary gland adenoid cystic carcinoma: Report of two cases. J Cancer Res Clin Oncol 2008;134: 1151-1153.
23. Nasser SM, Faquin WC, Dayal Y. Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors. Frequent expression of androgen receptor in a subset of malignant salivary gland tumors. Am J Clin Pathol 2003;119: 801-806.
24. Pires FR, da Cruz Perez DE, de Almeida OP, Kowalski LP. Estrogen receptor expression in salivary gland mucoepidermoid carcinoma and adenoid cystic carcinoma. Pathol Oncol Res 2004;10: 166-168.
25. Jeannon JP, Soames JV, Bell H, Wilson JA. Immunohistochemical detection of oestrogen and progesterone receptors in salivary tumours. Clin Otolaryngol Allied Sci 1999;24: 52-54.
26. Kiyoshima T, Shima K, Kobayashi I, et al. Expression of p53 tumor suppressor gene in adenoid cystic and mucoepidermoid carcinomas of the salivary glands. Oral Oncol 2001;37: 315-322.